Product Images Oxcarbazepine

The log-rank test analysis shows a p-value of 0.0001 for the Oxcarbazepine treatment group. The rest of the text appears to be a combination of numerical values and column/axis labels, but it is not available to determine their significance without additional context.*

This appears to be a graph showing the number of days from the first dose of a treatment (Oxcarbazeping or Placebo) to the first seizure. It seems to display time on the x-axis and number of days on the y-axis, and includes numbered and labeled ticks on both axes. There are also various numbered values plotted along the y-axis, likely indicating the number of days between doses or some other relevant time interval. The graph includes a key indicating which treatment group each color represents.*

The given text presents the results of a log-rank test with a p-value of 0.0001. The remaining text appears to be a graph with a horizontal axis showing the range of days for "Time to exit" and a treatment group represented by HIGH and LOW. However, the graph is not properly formatted and may not be useful for interpretation.*

Each 5 mL of the medicine contains 300 mg of oxcarbazepine, USP. The recommended dosage can be found in the package insert. The medicine should be stored in the original container at a temperature of 20° to 25°C (68° to 77°F); excursions up to 15° to 30°C (55°F to 86°F) are permitted. It should be used within 7 weeks of first opening the bottle and kept out of the reach of children. The medication should be shaken well before use. The medication guide should be dispensed to the patient by the pharmacist. This medicine is distributed by Epic Pharma, LLC in Lauretion, NY, and made in Canada. The NDC number is 42806-600-22.*

This is a medication label for Oxcarbazepine Oral Suspension, USP in the strength of 300mg/5mL. It is important to shake the bottle well before using, and the pharmacist should dispense medication guide provided separately to each patient. The medication should be stored in its original container and kept out of the reach of children. The NDC number for this product is 42806-600-22. The dosage information is available on the package, and the medication should be used within 7 weeks of opening.*